Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

Clinical trial evaluating tocotrienol for non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: National University of Malaysia | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: COMPLETED